---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "6H1Sb8EmQ4FWHIODqAtZDSv/+hcSMPXhlA+Rxzx+z/fbfqtLewBdChWcSDLant4E3hps/Ktx5wsv2oV6orm+Qu6SV0aQ5wmXhEz6Ac7MZOUZo1dAeC31Hkqxl/YHNm8Dz1JeLUbEWek/1TqdHO9g6FSmp+Iqz8uiO7vMzJAUVURFbpwaSX91YBwbNz33lcom6Ek1d8poU+Cx0XPbnphNSG+caoXgHfnGOPnSWu4DGteGFtZ1TRsXgBx4aChTg6AtNzErVuQ2LRYNdPndsawN4pa5G5Jl9YMgFtPLhXEso/B79HOTTNTBkbkigCL1Nj9OZpw1WZNP4lGGnO7a8KC6JiM1MgqlBgkc9ELyJfRwUIg=;Kzl31R0lFQLhztDI9wZqGw=="
---

